CDC25B and hepatocellular carcinoma: In summary, CDC25B, a key factor involved in cell cycle regulation (mainly G2/M phase), was shown to be overexpressed in HCC tumors and significantly correlated with poor prognosis and degree of tumor differentiation in HCC patients.